
Keywords: ایسکمی هیپوکسیک; Disease modifiers; Nutraceutical; Nutrition; Polyunsaturated fatty acids; Neuroprotection; Stroke outcome and recovery; ALA; alpha-linolenic acid; CA; Cornu Ammonis; DAB; 3,3â²-diaminobenzidine; DALYs; disability-adjusted life years; DHA; docosahexaenoic